Sort
261,768 grants matching “gene therapy”
Innovation through collaboration at the intersection of childhood development and cancer: a platform for the Gabriella Miller Kids First Pediatric Data Resource Center
$1,171,824Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2019 · HL
Innovation through collaboration at the intersection of childhood development and cancer: a platform for the Gabriella Miller Kids First Pediatric Data Resource Center
$1,171,824Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2020 · HL
Innovation through collaboration at the intersection of childhood development and cancer: a platform for the Gabriella Miller Kids First Pediatric Data Resource Center
$1,171,824Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2021 · HL
Identification of the genetic and transcriptomic networks of cognitive and neuropathological resilience to Alzheimer's Disease associated viruses
$1,171,622Benjamin Readhead · Arizona State University-Tempe Campus · U01 · FY2020 · AG
Novel patient-derived 3D platform for detecting TDP-43 proteinopathy and associated biomarkers for ALS/FTD
$1,171,621Martina De Majo · Synapticure, Inc. · R44 · FY2022 · NS
Microenvironmental control of progenitors in organ dysfunction and repair
$1,171,517Jay W Schneider · Ut Southwestern Medical Center · U01 · FY2014 · HL
Molecular genetics of MLL-associated leukemia
$1,171,454Manuel O Diaz · Loyola University Chicago · P01 · FY2006 · CA
Role of neurokinin 1 receptor signaling in keratinocytes in allergic contact dermatitis
$1,171,154Adriana T Larregina · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Novel Biologic Therapies for GVHD
$1,171,119Leslie S Kean · Boston Children'S Hospital · R01 · FY2022 · HL
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
$1,171,075Mark Thomas Gladwin · University Of Maryland Baltimore · UH3 · FY2025 · HL
Dissecting neuron-microglia-astrocyte interaction in AD pathogenesis
$1,171,075Junmin Peng · St. Jude Children'S Research Hospital · R01 · FY2024 · AG
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
$1,170,955Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · UH3 · FY2021 · HL
Immunology of Acute and Chronic Viral Hepatitis
$1,170,726Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
PROJECT 1: LONGITUDINAL STUDIES
$1,170,455Brendan Hl Lee · Baylor College Of Medicine · U54 · FY2019 · AR
Metabolic and neural activity normalization by cerebral blood flow increase in AD/ADRD models
$1,170,347Chris B Schaffer · Cornell University · R01 · FY2023 · AG
Role of inflammation, innate resistance, and immunity in carcinogenesis
$1,170,282Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Novel Targets for Immunotherapy
$1,170,238Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Discovery of B. pseudomallei therapeutics for Biodefense
$1,170,128Donald T Moir · Microbiotix, Inc · R44 · FY2007 · AI
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
$1,170,059Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2024 · CA
Molecular and Cellular Therapies for Muscular Dystrophy
$1,170,057Stanley C Froehner · University Of Washington · P01 · FY2013 · NS
Epi-genetic Programs in Cancer Progression
$1,170,000Robert A Weinberg · Whitehead Institute For Biomedical Res · R35 · FY2018 · CA
Sex Differences in Inflammation Across the Lifespan
$1,170,000Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R35 · FY2025 · NS
Epi-genetic Programs in Cancer Progression
$1,170,000Robert A Weinberg · Whitehead Institute For Biomedical Res · R35 · FY2020 · CA
Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS
$1,170,000Lin Guo · Thomas Jefferson University · RF1 · FY2021 · NS
Epi-genetic Programs in Cancer Progression
$1,170,000Robert A Weinberg · Whitehead Institute For Biomedical Res · R35 · FY2021 · CA